Contracted portfolio annual NOI
Company: Core Scientific
The claim, verbatim
Core Scientific expects the contracted portfolio to generate $1.6 billion in annual net operating income once fully delivered and billing.
Source (primary)
Core Scientific: 3 Key Takeaways for Long-Term Investors - Yahoo Finance (-, news_article)
View cached copy (2026-11-10)Live source ↗Archive.org ↗
Quote: “we expect that portfolio alone to generate $1.8 billion in average annual run rate revenue and $1.6 billion in NOI”
How we checked this
Checked on November 11, 2026. The cited source supports every part of this claim.
The article states the $1.6 billion annual net operating income projection and quotes the CEO saying it applies once the portfolio is fully delivered and billing.
Confirmed in the source:
- Core Scientific expects its contracted portfolio to generate $1.6 billion in annual net operating income
- The $1.6 billion figure applies once the portfolio is fully delivered and billing
What we did: Read our cached copy of the publisher (https://finance.yahoo.com/markets/stocks/articles/core-scientific-3-key-takeaways-134140731.html) in full (12,055 characters, retrieved November 10, 2026) and checked each assertion in the claim against it.
Additional evidence
confirms Core Scientific: 3 Key Takeaways for Long-Term Investors - Yahoo Finance
Quote: “we expect that portfolio alone to generate $1.8 billion in average annual run rate revenue and $1.6 billion in NOI”